SEE CORRESPONDING ARTICLE ON PAGE 9
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Biological PsychiatryAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Autoimmune encephalitis: A potentially treatable cause of mental disorder.Adv Psychiatr Treat. 2014; 20: 92-100
- Autoimmune psychosis: An international consensus on an approach to the diagnosis and management of psychosis of suspected autoimmune origin.Lancet Psychiatry. 2020; 7: 93-108
- The prevalence and treatment outcomes of antineuronal antibody-positive patients admitted with first episode of psychosis.BJPsych Open. 2018; 4: 69-74
- Encephalitis and psychosis.Br J Psychiatry. 2012; 200: 428
- The American Psychiatric Association Practice Guideline for the Treatment of Patients With Schizophrenia.American Psychiatric Association, Washington, DC2021
- Evidence-based guidelines for the pharmacological treatment of schizophrenia: Updated recommendations from the British Association for Psychopharmacology.J Psychopharmacol. 2020; 34: 3-78
- Seroprevalence of autoantibodies against brain antigens in health and disease.Ann Neurol. 2014; 76: 82-94
- Relationship between serum NMDA receptor antibodies and response to antipsychotic treatment in first-episode psychosis.Biol Psychiatry. 2021; 90: 9-15
- Amisulpride and olanzapine followed by open-label treatment with clozapine in first-episode schizophrenia and schizophreniform disorder (OPTiMiSE): A three-phase switching study.Lancet Psychiatry. 2018; 5: 797-807
- Psychiatric management of anti-NMDAR encephalitis: A cohort analysis.Psychol Med. 2021; 51: 435-440
Article info
Publication history
Accepted:
April 19,
2021
Received:
April 14,
2021
Identification
Copyright
© 2021 Society of Biological Psychiatry.
ScienceDirect
Access this article on ScienceDirectLinked Article
- Relationship Between Serum NMDA Receptor Antibodies and Response to Antipsychotic Treatment in First-Episode PsychosisBiological PsychiatryVol. 90Issue 1
- PreviewWhen psychosis develops in NMDA receptor (NMDAR) antibody encephalitis, it usually has an acute or subacute onset, and antipsychotic treatment may be ineffective and associated with adverse effects. Serum NMDAR antibodies have been reported in a minority of patients with first-episode psychosis (FEP), but their role in psychosis onset and response to antipsychotic treatment is unclear.
- Full-Text
- Preview
